BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35008688)

  • 21. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
    Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
    Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.
    Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D
    Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
    Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
    Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses.
    Martín Almazán N; Sala BM; Sandalova T; Sun Y; Resink T; Cichocki F; Söderberg-Nauclér C; Miller JS; Achour A; Sarhan D
    Front Immunol; 2023; 14():1230718. PubMed ID: 37809084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
    Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
    Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
    Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity.
    Pump WC; Schulz R; Huyton T; Kunze-Schumacher H; Martens J; Hò GT; Blasczyk R; Bade-Doeding C
    HLA; 2019 Jul; 94(1):25-38. PubMed ID: 30912293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytomegalovirus expands a CD8
    Sottile R; Panjwani MK; Lau CM; Daniyan AF; Tanaka K; Barker JN; Brentjens RJ; Sun JC; Le Luduec JB; Hsu KC
    Sci Immunol; 2021 Sep; 6(63):eabe6968. PubMed ID: 34559552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.
    Rousselière A; Charreau B
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.
    Wang EC; Taylor-Wiedeman J; Perera P; Fisher J; Borysiewicz LK
    Clin Exp Immunol; 1993 Nov; 94(2):297-305. PubMed ID: 7693383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCMV seropositivity is associated with specific proinflammatory immune phenotype in women with implantation failure.
    Dons'koi BV; Tutchenko TM; Chernyshov VP; Stepaniuk KS
    Immunol Lett; 2020 Jan; 217():84-90. PubMed ID: 31756347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
    Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
    Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.
    Wallace DL; Masters JE; De Lara CM; Henson SM; Worth A; Zhang Y; Kumar SR; Beverley PC; Akbar AN; Macallan DC
    Immunology; 2011 Jan; 132(1):27-38. PubMed ID: 20738423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
    Newhook N; Fudge N; Grant M
    Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of NK cell receptor repertoire in adults and very elderly subjects with cytomegalovirus infection.
    Juárez-Vega G; Rangel-Ramírez V; Monsiváis-Urenda A; Niño-Moreno P; Garcia-Sepúlveda C; Noyola DE; González-Amaro R
    Hum Immunol; 2017 Mar; 78(3):274-280. PubMed ID: 28093266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.